HTX vs Mira — how do they compare? HTX trades at Rp0.0322 (market cap Rp28,89T, Rp304,4M 24h volume), while Mira trades at Rp703.62 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: HTX is far larger — about 127589.1× Mira's market cap, and HTX's circulating supply is 898,2T / 1.000T HTX (90%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold HTX for 22 Days and Mira for 22 Days on average.
| HTX | MIRA | |
|---|---|---|
Market Cap | Rp28,89T | Rp226,43M |
Volume (24h) | Rp304,4M | Rp101,47M |
Circulating Supply | 898,2T / 1.000T HTX (90%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 22 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
HTX token shows strong bullish momentum with current price at Rp0.0325 and market cap of Rp29.24T, supported by overwhelmingly positive moving average signals (13 buy vs 0 sell). The token has 90% of its maximum 1.000T supply in circulation with average hold time of 22 days. Technical indicators show ADX readings above 60 indicating strong trend strength, while RSI remains in neutral territory suggesting room for further upside.
Overall outlook is bullish with strong technical momentum, though limited fundamental updates and neutral oscillators suggest cautious optimism. Key opportunities include continued trend following, while risks involve high volatility and lack of recent ecosystem developments. Investors should monitor for protocol updates and exchange liquidity changes.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
Latest headlines on both assets
HTX is the native token of HTX DAO, a decentralized organization that supports the decentralized economy. It facilitates transactions, offers fee discounts, and provides access to exclusive features and services. Token holders can also participate in governance through voting. HTX is designed to support contributors, community programs, partnerships, and platform growth while promoting liquidity through voluntary pledging. Operating without formal registration, HTX DAO prioritizes autonomy, transparency, and inclusivity, making the HTX token essential for innovation, governance, and ecosystem growth in the blockchain space.
Read more on HTX →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →